Page 158 - Molecular features of low-grade developmental brain tumours

Patient Diagnose Gender Localization
Age of surgery Age of seizure onset (years) (years)
6
CHAPTER 6
Table 1. Summary of clinical fifindings of glioneuronal tumours (GNTs)
1a,c GG 2a,c GG 3a,c GG 4a,c GG
5a,b,c GG 6a,c GG 7a,b GG 8a,c GG
9a GG 10a GG 11a,b GG 12a GG 13a GG 14a GG 15b GG 16b GG 17b GG 18b GG 19b GG 20b GG 21b GG 22b GG 23b GG 24b GG 25b GG 26b GG
27a DNT
28a DNT
29a DNT
30a DNT
31a DNT
32a DNT
33a DNT
34a DNT
Female Female Maleale Female Male Female Female Female Female Male Male Female Male Female Female Male Male Male Female Male Female Male Female Female Male Female Female Male Male Male Female Female Female Male Female
T 29 T 11 T 16 T 42 T 21 T 14 P 24 T 23 T 19 T 18 P 28 T 34 T 20 T 49 T 28 T 10 T 18 T 44 T 6 P 42 B 29 T 33 T 22 C 48 T 34 T 56 T 15 T 41 T 11 T 8 T 30 F 11 T 16 T 35 T 15
13
8
14
11
13
11
24
14
15
13
28
11
11
19
12
9
17
20
3
1
No seizures 18
10
No seizures 16
52
11
19
10
2
25
8
14
17
5
35a DNT
aFFPE (formalin-fixed, paraffin-embedded) tissue; bFrozen tissue; cPeritumoural cortex tissue.
156
Gangliogliomas (GG) and dysembryoplastic neuroepithelial tumours (DNT).